The role played by these pathways and their potential convergence with each other has received a renewed interest following the observation that Clusterin and the C1q receptor, an early component of the complement cascade, are significant genetic determinants of late onset AD (72, 73). This evidence concerns the gene CLU and Alzheimer disease.